Organization
Dept. of Gastroenterology
2 abstracts
Abstract
INSIGHT-005: A new stratum of the explorative, open-labeled, phase I INSIGHT study to evaluate the feasibility and safety, as well as preliminary efficacy, of subcutaneous injections with IMP321 (eftilagimod alpha) in combination with PD-L1 inhibitor (avelumab) for metastatic or unresectable locally advanced urothelial carcinoma (UC)—IKF-s614.Org: Universitätsklinik Tübingen, Klinik für Urologie, University Medical Center of the Johannes Gutenberg-University Mainz, Hematology Oncology Practice Eppendorf (HOPE), University Cancer Center Hamburg (UCCH),
Abstract
AXIAL AND PERIPHERAL MANIFESTATION IN SPONDYLOARTHRITIS: A WHOLE BODY MRI APPROACHOrg: Dept. of radiology, Institute of Rheumatology, Prague, Dept. of Gastroenterology, Infectiology and Rheumatology, Charité Medical School, Berlin, Germany,